D. E. Shaw & Co. Inc. Has $26.15 Million Position in Teleflex Incorporated (NYSE:TFX)

D. E. Shaw & Co. Inc. increased its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 232.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 146,944 shares of the medical technology company's stock after buying an additional 102,804 shares during the period. D. E. Shaw & Co. Inc. owned 0.32% of Teleflex worth $26,153,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. CANADA LIFE ASSURANCE Co boosted its position in Teleflex by 0.4% during the fourth quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company's stock worth $3,614,000 after purchasing an additional 74 shares during the period. Hengehold Capital Management LLC boosted its position in shares of Teleflex by 7.3% in the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company's stock valued at $229,000 after acquiring an additional 88 shares during the period. Exchange Traded Concepts LLC grew its stake in shares of Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after acquiring an additional 94 shares in the last quarter. Isthmus Partners LLC grew its stake in shares of Teleflex by 7.3% in the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company's stock valued at $273,000 after acquiring an additional 105 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in shares of Teleflex by 2.4% in the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company's stock valued at $888,000 after acquiring an additional 118 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Price Performance

NYSE TFX traded up $2.66 during trading on Friday, hitting $129.15. 542,769 shares of the company's stock were exchanged, compared to its average volume of 638,696. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a market cap of $5.71 billion, a PE ratio of 25.67, a P/E/G ratio of 1.73 and a beta of 1.17. Teleflex Incorporated has a fifty-two week low of $120.06 and a fifty-two week high of $249.91. The stock's 50 day moving average price is $132.83 and its two-hundred day moving average price is $162.64.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business's quarterly revenue was down 5.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.21 earnings per share. Research analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.05%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex's dividend payout ratio is currently 42.90%.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Mizuho set a $155.00 price target on shares of Teleflex in a research note on Wednesday, April 16th. Citizens Jmp downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 27th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. StockNews.com downgraded shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Finally, Royal Bank of Canada decreased their price target on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research note on Friday, May 2nd. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $164.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.